Biotech Values

[rkrw]

No doubt. What i was hoping for is more progress on the rest of the company, M118, oncology, other programs with nvs, etc to bump up the downside base value. As far as approval, i know of no way to discount the outcome. It's not like an NDA where you can check the boxes, efficacy, side effects, need.